https://advisory.avalerehealth.com/insights/novel-antibiotic-use-is-low-even-for-complex-cases
Novel antibiotic development has been relatively stagnant for decades, despite critical unmet need and the development of antimicrobial resistance (AMR) around
antibiotic usecomplex casesnovelloweven
https://advisory.avalerehealth.com/insights/proposed-ma-plan-payment-changes-may-impact-premiums-and-benefits
On February 1, the Centers for Medicare & Medicaid Services (CMS) released the 2024 Advance Notice, an annual regulatory document that describes the...
plan paymentproposedchangesmayimpact
https://advisory.avalerehealth.com/products
Avalere's subscription services provide insights from our healthcare experts on topics such as health policy, drug coverage analysis, and quality measures.
avalere health advisoryproducts